Forum
Welcome, Guest
Username: Password:

Login With Facebook

Welcome to the CAOOY forum!
  • Page:
  • 1

TOPIC: The Price of ADHD Business

The Price of ADHD Business 25 Mar 2014 15:51 #322

The Price of ADHD Business
Posted March 17, 2014 by Frank J. Granett R.ph



Over 12 million children and young adults consume ADHD stimulant and psychiatric medications in the United States. Pharmaceutical corporations generated near 9 billion dollars in 2012 for ADHD stimulant drug sales, representing 5x the 1.7 billion in sales ten years ago. More alarming, this rate of consumption represents 3x the world's children combined, according to data collected by Scientific American. The business model of behaviorally assessing and prematurely medicating young school age children with powerful stimulant and psychoactive drug therapy for over 40 years is now under fire. The Government Accountability Office (GAO) Child Foster Care Drug Audit Report uncovered dangerous and unethical prescribing practices. Widespread abuses of overmedicating young foster care children with ADHD stimulant as well as psychiatric medications prior to ruling out nutritional, physiological, and environmental risk factors were uncovered by the largest child foster care prescription drug audit in American history.

In today's America parents, educators, and prominent healthcare professionals challenge the 40-year ADHD business model, as the ADHD diagnosis rate surpasses epidemic status in 2014. The symptoms of ADHD are real and in many cases can be debilitating to children as well as adults. Especially in the young child population, the ADHD business model of assessment and treatment requires immediate reform. Children have a right to receive comprehensive bio-assessments as well as behavioral assessments to determine cause of their symptoms prior to powerful stimulant and psychoactive drug therapy.

The Diagnostic and Statistical Manual for Mental disorders (DSM) lists ADHD as a mental disorder. The DSM diagnosing criteria, created by psychiatrists, involves a subjective behavioral assessment process which forces children primarily into premature drug therapy. Although seven out of ten children may exhibit an initial positive behavioral response to stimulant drug therapy for focus and attention, the long term side effects are now known.

...

Continue reading: http://usdailyreview.com/the-price-of-adhd-business/
The administrator has disabled public write access.
  • Page:
  • 1
Time to create page: 0.104 seconds

The mission of the Coalition Against Overmedicating Our Youth is to help children and adults determine underlying cause of neuro-behavioral conditions by ruling out nutritional, physiological, and environmental risk factors prior to premature drug therapy.

Donate

Book: THE AMERICAN EPIDEMIC

Give the gift of knowledge.
Help determine the cause
of behavioral challenges,
prior to drug therapy.
All proceeds donated to CAOOY.



Order your copy on Amazon.com here,
or get your autographed copy direct from the author via PayPal below.
Free shipping
.

 

Preview the CAOOY Educational DVD.

 

Select Book, DVD, or Combo:
Referred by:

 

Featured Article

"How Environmental Toxins Affect the Onset of ADHD"
by Frank J. Granett R.ph. featured on
USDailyReview.com

View article